New Drug For Heart Failure In Dogs Approved

Vetmedica Inc.’s new heart failure drug, Vetmedin, has been approved by the USDA.

The U.S. Food and Drug Administration has approved Boehringer Ingelheim Vetmedica Inc.’s Vetmedin (pimobendan) for the management of the signs of mild, moderate or severe congestive heart failure in dogs due to atrioventricular valvular insufficiency or dilated cardiomyopathy.

Vetmedin, which is the first drug approved to treat congestive heart failure in dogs in more than ten years, is indicated for use with concurrent therapy for congestive heart failure as appropriate on a case-by-case basis, according to the FDA.

Vetmedin helps alleviate signs of heart failure by increasing contractility and by dilating blood vessels, according to the FDA.

Adverse reactions associated with Vetmedin were potentially related to congestive heart failure, the therapy of congestive heart failure or both and included poor appetite, lethargy, diarrhea, worsening signs of heart failure, heart failure death, azotemia and mild increases in serum liver enzymes.

Vetmedin is not for use in cats.

For more information, visit www.fda.gov

<HOME>

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *

___

Register

Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).
 

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.